156 related articles for article (PubMed ID: 18005731)
1. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function.
Kim J; Thanabalasuriar A; Chaworth-Musters T; Fromme JC; Frey EA; Lario PI; Metalnikov P; Rizg K; Thomas NA; Lee SF; Hartland EL; Hardwidge PR; Pawson T; Strynadka NC; Finlay BB; Schekman R; Gruenheid S
Cell Host Microbe; 2007 Sep; 2(3):160-71. PubMed ID: 18005731
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
Thanabalasuriar A; Kim J; Gruenheid S
Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
[TBL] [Abstract][Full Text] [Related]
3. Sec24 interaction is essential for localization and virulence-associated function of the bacterial effector protein NleA.
Thanabalasuriar A; Bergeron J; Gillingham A; Mimee M; Thomassin JL; Strynadka N; Kim J; Gruenheid S
Cell Microbiol; 2012 Aug; 14(8):1206-18. PubMed ID: 22432415
[TBL] [Abstract][Full Text] [Related]
4. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S
Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078
[TBL] [Abstract][Full Text] [Related]
5. Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation.
Yen H; Sugimoto N; Tobe T
PLoS Pathog; 2015 Sep; 11(9):e1005121. PubMed ID: 26332984
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence of host-mediated glycosylation of NleA and its dependence on interaction with the COPII complex.
Burns L; Le Mauff F; Gruenheid S
Gut Microbes; 2024; 16(1):2305477. PubMed ID: 38298145
[TBL] [Abstract][Full Text] [Related]
7. The bacterial virulence factor NleA undergoes host-mediated O-linked glycosylation.
Burns L; Giannakopoulou N; Zhu L; Xu YZ; Khan RH; Bekal S; Schurr E; Schmeing TM; Gruenheid S
Mol Microbiol; 2023 Feb; 119(2):161-173. PubMed ID: 36196760
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7.
Gruenheid S; Sekirov I; Thomas NA; Deng W; O'Donnell P; Goode D; Li Y; Frey EA; Brown NF; Metalnikov P; Pawson T; Ashman K; Finlay BB
Mol Microbiol; 2004 Mar; 51(5):1233-49. PubMed ID: 14982621
[TBL] [Abstract][Full Text] [Related]
9. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.
Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA
Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331
[TBL] [Abstract][Full Text] [Related]
10. A rapid and quantitative coat protein complex II vesicle formation assay using luciferase reporters.
Fromme JC; Kim J
Anal Biochem; 2012 Feb; 421(2):482-8. PubMed ID: 22244805
[TBL] [Abstract][Full Text] [Related]
11. Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue.
Nobe R; Nougayrède JP; Taieb F; Bardiau M; Cassart D; Navarro-Garcia F; Mainil J; Hayashi T; Oswald E
Microbiology (Reading); 2009 Oct; 155(Pt 10):3214-3225. PubMed ID: 19628559
[TBL] [Abstract][Full Text] [Related]
12. TRAPPI tethers COPII vesicles by binding the coat subunit Sec23.
Cai H; Yu S; Menon S; Cai Y; Lazarova D; Fu C; Reinisch K; Hay JC; Ferro-Novick S
Nature; 2007 Feb; 445(7130):941-4. PubMed ID: 17287728
[TBL] [Abstract][Full Text] [Related]
13. A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium.
Lee SF; Kelly M; McAlister A; Luck SN; Garcia EL; Hall RA; Robins-Browne RM; Frankel G; Hartland EL
Cell Microbiol; 2008 Feb; 10(2):499-513. PubMed ID: 17979986
[TBL] [Abstract][Full Text] [Related]
14. Control of Type III Secretion System Effector/Chaperone Ratio Fosters Pathogen Adaptation to Host-Adherent Lifestyle.
Elbaz N; Socol Y; Katsowich N; Rosenshine I
mBio; 2019 Sep; 10(5):. PubMed ID: 31530678
[TBL] [Abstract][Full Text] [Related]
15. Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli.
Loukiadis E; Nobe R; Herold S; Tramuta C; Ogura Y; Ooka T; Morabito S; Kérourédan M; Brugère H; Schmidt H; Hayashi T; Oswald E
J Bacteriol; 2008 Jan; 190(1):275-85. PubMed ID: 17873042
[TBL] [Abstract][Full Text] [Related]
16. NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA.
Yen H; Ooka T; Iguchi A; Hayashi T; Sugimoto N; Tobe T
PLoS Pathog; 2010 Dec; 6(12):e1001231. PubMed ID: 21187904
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.
Yen H; Karino M; Tobe T
Front Cell Infect Microbiol; 2016; 6():89. PubMed ID: 27617233
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of the type III secretion system activity of enteropathogenic Escherichia coli.
Mills E; Baruch K; Aviv G; Nitzan M; Rosenshine I
mBio; 2013 Jul; 4(4):. PubMed ID: 23900171
[TBL] [Abstract][Full Text] [Related]
19. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F
Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286
[TBL] [Abstract][Full Text] [Related]
20. EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function.
Clements A; Smollett K; Lee SF; Hartland EL; Lowe M; Frankel G
Cell Microbiol; 2011 Sep; 13(9):1429-39. PubMed ID: 21740499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
